The concentration of sTREM2 in the CSF is a sensitive marker of microglial activation and was reported to correlate with the prevalence of tau-mediated AD (Henjum et al., 2018; Wilson et al., 2020). The gene discussed is MAPT; the disease is Alzheimer disease.